BRIEF-Xenon Pharmaceuticals Q4 Net Income USD -105.261 Million Vs. IBES Estimate USD -95.9 Million

Reuters02-27
BRIEF-Xenon Pharmaceuticals Q4 Net Income USD -105.261 Million Vs. IBES Estimate USD -95.9 Million

Feb 26 (Reuters) - Xenon Pharmaceuticals Q4 income from operations USD -109.767 million.

  • Q4 operating expenses USD 109.767 million

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment